William A. May

1.3k total citations
17 papers, 1.0k citations indexed

About

William A. May is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, William A. May has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in William A. May's work include Sarcoma Diagnosis and Treatment (8 papers), Genetic factors in colorectal cancer (3 papers) and Protein Degradation and Inhibitors (3 papers). William A. May is often cited by papers focused on Sarcoma Diagnosis and Treatment (8 papers), Genetic factors in colorectal cancer (3 papers) and Protein Degradation and Inhibitors (3 papers). William A. May collaborates with scholars based in United States and Canada. William A. May's co-authors include Christopher T. Denny, Benjamin S. Braun, Stephen L. Lessnick, Jeffrey P. Zwerner, Timothy J. Triche, Andrew Thompson, Marcienne M. Wright, Afsane Arvand, C. Patrick Reynolds and Laura Christensen and has published in prestigious journals such as Nature Genetics, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

William A. May

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William A. May United States 12 662 499 267 171 161 17 1.0k
Savita Sankar United States 10 532 0.8× 426 0.9× 134 0.5× 130 0.8× 120 0.7× 12 833
Carlos Mackintosh Spain 15 456 0.7× 303 0.6× 200 0.7× 102 0.6× 159 1.0× 20 765
Giovanna Magagnoli Italy 22 516 0.8× 694 1.4× 360 1.3× 156 0.9× 255 1.6× 53 1.2k
Vanessa Cerisano Italy 11 396 0.6× 318 0.6× 183 0.7× 94 0.5× 163 1.0× 11 750
Matteo Trucco United States 17 354 0.5× 392 0.8× 322 1.2× 96 0.6× 160 1.0× 37 992
Tom Lesluyes France 18 353 0.5× 325 0.7× 280 1.0× 86 0.5× 230 1.4× 38 816
Ana Cristina Vargas Australia 17 637 1.0× 254 0.5× 376 1.4× 98 0.6× 472 2.9× 36 1.1k
Heidi M. Namløs Norway 16 680 1.0× 400 0.8× 242 0.9× 93 0.5× 576 3.6× 23 1.2k
Valentina Biasin Austria 12 518 0.8× 314 0.6× 242 0.9× 58 0.3× 124 0.8× 16 915
Kelly J. Gordon United States 7 701 1.1× 121 0.2× 315 1.2× 79 0.5× 156 1.0× 10 1.0k

Countries citing papers authored by William A. May

Since Specialization
Citations

This map shows the geographic impact of William A. May's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William A. May with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William A. May more than expected).

Fields of papers citing papers by William A. May

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William A. May. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William A. May. The network helps show where William A. May may publish in the future.

Co-authorship network of co-authors of William A. May

This figure shows the co-authorship network connecting the top 25 collaborators of William A. May. A scholar is included among the top collaborators of William A. May based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William A. May. William A. May is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kurzer, Jason H., Jean Oak, Liora M. Schultz, et al.. (2022). Targeted Mutational Profiling Reveals Clonal Relationships in Metachronous Occurrence of Classic Hodgkin and Mediastinal Large B-Cell Lymphomas. The American Journal of Surgical Pathology. 47(1). 81–90. 5 indexed citations
2.
Crane, Jacquelyn, et al.. (2019). Burkitt-like lymphoma in a pediatric patient with familial adenomatous polyposis. Cancer Genetics. 239. 33–35. 4 indexed citations
3.
May, William A., Nino Keshelava, Laura Christensen, et al.. (2013). Characterization and Drug Resistance Patterns of Ewing's Sarcoma Family Tumor Cell Lines. PLoS ONE. 8(12). e80060–e80060. 45 indexed citations
4.
Christensen, Laura, et al.. (2013). FOXM1 Is an Oncogenic Mediator in Ewing Sarcoma. PLoS ONE. 8(1). e54556–e54556. 35 indexed citations
5.
Lindsay, Holly, Rima Jubran, Larry Wang, Benjamin R. Kipp, & William A. May. (2013). Simultaneous Colonic Adenocarcinoma and Medulloblastoma in a 12-Year-Old with Biallelic Deletions in PMS2. The Journal of Pediatrics. 163(2). 601–603. 8 indexed citations
6.
Mitra, Anirban P., et al.. (2013). Abstract PR04: Genomic and epigenomic interactions of an Ewing sarcoma-specific long noncoding RNA. Cancer Research. 73(13_Supplement). PR04–PR04. 1 indexed citations
7.
Christensen, Laura, et al.. (2009). GLI1 Is a Central Mediator of EWS/FLI1 Signaling in Ewing Tumors. PLoS ONE. 4(10). e7608–e7608. 67 indexed citations
8.
Kang, Hyung‐Gyoo, Nino Keshelava, Hiroyuki Shimada, et al.. (2007). E-Cadherin Cell-Cell Adhesion in Ewing Tumor Cells Mediates Suppression of Anoikis through Activation of the ErbB4 Tyrosine Kinase. Cancer Research. 67(7). 3094–3105. 146 indexed citations
9.
Zwerner, Jeffrey P., Jennifer S. Guimbellot, & William A. May. (2003). EWS/FLI function varies in different cellular backgrounds. Experimental Cell Research. 290(2). 414–419. 26 indexed citations
10.
Zwerner, Jeffrey P. & William A. May. (2002). Dominant negative PDGF-C inhibits growth of Ewing family tumor cell lines. Oncogene. 21(24). 3847–3854. 43 indexed citations
11.
Zwerner, Jeffrey P. & William A. May. (2001). PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors. Oncogene. 20(5). 626–633. 98 indexed citations
12.
May, William A., Afsane Arvand, Andrew Thompson, et al.. (1997). EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic. Nature Genetics. 17(4). 495–497. 128 indexed citations
13.
Braun, Benjamin S., et al.. (1995). Identification of Target Genes for the Ewing's Sarcoma EWS/FLI Fusion Protein by Representational Difference Analysis. Molecular and Cellular Biology. 15(8). 4623–4630. 141 indexed citations
14.
Thomas, Stephen H., Charles K. Stone, & William A. May. (1995). Exacerbation of verapamil-induced hyperglycemia with glucagon. The American Journal of Emergency Medicine. 13(1). 27–29. 4 indexed citations
15.
Stone, Charles K., William A. May, & Robert Carroll. (1995). Treatment of Verapamil Overdose With Glucagon in Dogs. Annals of Emergency Medicine. 25(3). 369–374. 19 indexed citations
16.
Lessnick, Stephen L., Benjamin S. Braun, Christopher T. Denny, & William A. May. (1995). Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.. PubMed. 10(3). 423–31. 153 indexed citations
17.
May, William A., Stephen L. Lessnick, Benjamin S. Braun, et al.. (1993). The Ewing’s Sarcoma EWS/FLI-1 Fusion Gene Encodes a More Potent Transcriptional Activator and is a More Powerful Transforming Gene than FLI-1. Molecular and Cellular Biology. 13(12). 7393–7398. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026